These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 18926322)

  • 1. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.
    Martin SS; Qasim A; Reilly MP
    J Am Coll Cardiol; 2008 Oct; 52(15):1201-10. PubMed ID: 18926322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease.
    Wannamethee SG; Tchernova J; Whincup P; Lowe GD; Kelly A; Rumley A; Wallace AM; Sattar N
    Atherosclerosis; 2007 Apr; 191(2):418-26. PubMed ID: 16712853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leptin--adipose tissue hormone and its role in cardiovascular diseases].
    Racek-Król B
    Pol Merkur Lekarski; 2006 Jun; 20(120):713-6. PubMed ID: 17007277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin resistance and diet-induced obesity: central and peripheral actions of leptin.
    Sáinz N; Barrenetxe J; Moreno-Aliaga MJ; Martínez JA
    Metabolism; 2015 Jan; 64(1):35-46. PubMed ID: 25497342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overweight, hypertension and cardiovascular disease: focus on adipocytokines, insulin, weight changes and natriuretic peptides.
    Seven E
    Dan Med J; 2015 Nov; 62(11):B5163. PubMed ID: 26522487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin signaling and obesity: cardiovascular consequences.
    Yang R; Barouch LA
    Circ Res; 2007 Sep; 101(6):545-59. PubMed ID: 17872473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis.
    Kshatriya S; Reams GP; Spear RM; Freeman RH; Dietz JR; Villarreal D
    Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):72-8. PubMed ID: 19851106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin and cardiovascular diseases.
    Luo JD; Zhang GS; Chen MS
    Drug News Perspect; 2005 Sep; 18(7):427-31. PubMed ID: 16362081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin, obesity and cardiovascular disease.
    Correia ML; Haynes WG
    Curr Opin Nephrol Hypertens; 2004 Mar; 13(2):215-23. PubMed ID: 15202616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin and hyperleptinemia - from friend to foe for cardiovascular function.
    Ren J
    J Endocrinol; 2004 Apr; 181(1):1-10. PubMed ID: 15072562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of leptin.
    Sweeney G
    Nat Rev Cardiol; 2010 Jan; 7(1):22-9. PubMed ID: 19949425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.
    Correia ML; Rahmouni K
    Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease.
    Patel SB; Reams GP; Spear RM; Freeman RH; Villarreal D
    Curr Hypertens Rep; 2008 Apr; 10(2):131-7. PubMed ID: 18474180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin and cardiovascular diseases.
    Hou N; Luo JD
    Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):905-13. PubMed ID: 21957899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin and the cardiovascular system.
    Rahmouni K; Haynes WG
    Recent Prog Horm Res; 2004; 59():225-44. PubMed ID: 14749504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin, a mediator of cardiac damage associated with obesity.
    Martínez-Martínez E; Jurado-López R; Cervantes-Escalera P; Cachofeiro V; Miana M
    Horm Mol Biol Clin Investig; 2014 Apr; 18(1):3-14. PubMed ID: 25389996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
    Goralski KB; Sinal CJ
    Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.